Lv4
490 积分 2025-08-04 加入
ADR-Fusion: A Multi-modal Deep Learning Framework for Dynamic Drug Safety and Explainable Clinical Decision Support
18天前
已完结
Benchmarking of Saudi pharmacovigilance inspection standards across international regulatory authorities
29天前
已完结
Using Artificial Intelligence to Identify Patterns and Predictors of Adverse Drug Reactions in Cardiovascular Patients: A Comprehensive Narrative Review
1个月前
已完结
A Regulatory-Ready Bayesian Evidence Framework across Clinical Development and Pharmacovigilance: Practical Expectations from FDA, EMA, and ICH Guidance
1个月前
已完结
Integrating human and artificial intelligence for robust postmarketing safety surveillance systems: reflections from the FDA Sentinel Innovation Center
1个月前
已完结
Explainable Artificial Intelligence in Pharmacovigilance and Drug Safety: A Systematic Review of Enhancing Transparency and Regulatory Acceptance
2个月前
已完结
Understanding the Added Value of Action Limits for QTL Monitoring
2个月前
已完结
Clinical Risk Management and Patient-safety Research: A Large-scale Bibliometric Mapping of the Field and Its Emerging Directions (Master vs. 2021-2025)
2个月前
已完结
Realistic Drug Label Prediction Using Machine Learning
2个月前
已完结
Evidence on medicines use and safety during pregnancy: pharmacovigilance or pharmacodrowsinesss ?
2个月前
已完结
皖公网安备34019202002308
